| abstract |
A prophylactic or therapeutic agent for fibrodysplasia ossificans progressiva, said agent comprising as an active ingredient at least one compound selected from the group consisting of rapamycin, temsirolimus, everolimus, ridaforolimus, TAFA93, umirolimus, olcorolimus, zotarolimus and pharmaceutically acceptable salts thereof. |